UTICA — ConMed Corp. (NYSE: CNMD), a Utica–based surgical-device maker, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents a share for the fourth quarter. The dividend is payable on Jan. 5 to all shareholders of record as of Dec. 15. ConMed provides surgical devices and equipment for […]
Get Instant Access to This Article
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
- Critical Central New York business news and analysis updated daily.
- Immediate access to all subscriber-only content on our website.
- Get a year's worth of the Print Edition of The Central New York Business Journal.
- Special Feature Publications such as the Book of Lists and Revitalize Greater Binghamton, Mohawk Valley, and Syracuse Magazines
Click here to purchase a paywall bypass link for this article.
UTICA — ConMed Corp. (NYSE: CNMD), a Utica–based surgical-device maker, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents a share for the fourth quarter.
The dividend is payable on Jan. 5 to all shareholders of record as of Dec. 15.
ConMed provides surgical devices and equipment for minimally invasive procedures. The firm’s products are used by surgeons and physicians in specialties that include orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.
ConMed reported net sales of nearly
$610 million through the first nine months of 2020, down almost 12 percent from more than $690 million in the first three quarters of 2019.